Clinical trials
Chronic Respiratory Disease clinical trials
Below are recruiting chronic respiratory disease clinical trials, each written for real people, not researchers. We’re tracking 238 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05976919Recruiting
Testing different treatable traits in lung disease and controls
This study looks at “treatable traits” (specific features of lung disease) across people with chronic airflow problems, including cystic fibrosis, and compares them with healthy volunteers. You may be asked to do several breathing and exercise tests to see how well different traits can be measured and how they relate to symptoms.
Leeds, LeedsAges 18–65 - NCT06603246RecruitingPhase 1
Study of inhaled GDC-6988 for mucus lung diseases
This study tests an inhaled medicine (GDC-6988) to see if it is safe and helps clear mucus from the lungs in people with mucus-related lung diseases like chronic bronchitis, COPD, or bronchiectasis. You may qualify if your lung function is fairly stable and you produce daily mucus.
Birmingham, AlabamaAges 18 years+ - NCT06855004Recruiting
Study of severe breathing problems in people with lung scarring
This study follows patients with chronic lung scarring (fibrosing interstitial lung disease) who are in the intensive care unit for severe breathing failure. It aims to better understand their condition and care, which may help improve future treatments.
BobignyAges 18 years+ - NCT05866302Recruiting
CT breathing-scan test to detect chronic lung injury after transplant
This study uses a special way to analyze breathing-related CT images to find early or ongoing lung injury after an allogeneic stem cell transplant. It may help clinicians recognize chronic lung complications sooner and better guide care.
Stanford, CaliforniaAges 3 years+ - NCT07177339RecruitingPhase 3
Testing depemokimab for COPD with type 2 inflammation
This study tests an early treatment called depemokimab for people with moderate to severe COPD who have a type of inflammation linked to high eosinophils. It aims to reduce flare-ups and improve breathing.
Newport Beach, CaliforniaAges 40–75 - NCT07727915Enrolling by invitation
Using genetics to predict chronic disease risk
This trial uses genetic information to help predict your risk of developing chronic diseases. It aims to create a platform that can identify health risks earlier so you can take preventive steps.
Medellín, AntioquiaAges 18–99 - NCT06670443Recruiting
Electrical stimulation for COPD breathing and leg muscles
This trial tests if electrical stimulation can help people with COPD strengthen both their breathing and leg muscles. It may improve your ability to move and breathe more easily.
DokkiAges 40–65 - NCT07293429Recruiting
Posture and breathing training for COPD with forward head posture
This study tests a program that combines posture correction and breathing muscle exercises for people with COPD who also have a forward head posture. It aims to improve breathing and reduce shortness of breath.
LahoreAges 40–60 - NCT06074614Recruiting
Breathing and brain control in Parkinson's disease
This study looks at how the brain controls breathing in people with Parkinson's disease compared to healthy volunteers. It may help us understand breathing problems that can occur in Parkinson's.
Nijmegen, GelderlandAges 18 years+ - NCT07214571RecruitingPhase 2
Study of S-337395 for RSV in high-risk adults
This trial tests an experimental drug called S-337395 for adults with RSV who are not in the hospital but are at high risk for severe illness. It aims to see if the drug can help prevent symptoms from getting worse.
Los Angeles, CaliforniaAges 18 years+ - NCT06817889RecruitingPhase 2
Remdesivir for RSV in people with weak immune systems
This trial tests if remdesivir can safely treat RSV (a respiratory virus) in people with weakened immune systems, such as those who have had a stem cell or bone marrow transplant, CAR T-cell therapy, or are being treated for blood cancer. If you have a confirmed RSV infection in your nose or throat and are at moderate or high risk for complications, you may be able to join.
Duarte, CaliforniaAges 18 years+ - NCT06571942RecruitingPhase 4
Triple therapy for lung disease from biomass smoke
This trial is testing a combination of three inhaled medicines (triple therapy) to see how well they help the small airways in people whose lung disease is caused by breathing in smoke from cooking or heating with wood or other biomass fuels. It may be a good fit if you have COPD or chronic bronchitis from this type of exposure.
Mexico City, TlalpanAges 35–85 - NCT06739928RecruitingPhase 2
Irinotecan liposome with immunotherapy for extensive-stage small cell lung cancer
This trial tests a combination of irinotecan liposome (a chemotherapy) or etoposide with adebrelimab (an immunotherapy) and carboplatin for people with extensive-stage small cell lung cancer who haven't had prior treatment. It aims to see if these combinations are safe and effective.
Guangzhou, GuangzhouAges 18–70 - NCT07543380RecruitingPhase 3
RSV vaccine safety and immune response in high-risk adults
This study tests a new RSV vaccine designed to protect adults with chronic health conditions from severe RSV disease (a respiratory infection). Researchers will monitor how safe the vaccine is and how well your immune system responds to it.
Tsuchiura, IbarakiAges 18–59 - NCT04461821Recruiting
Breath test to study disease in children
This study uses a special machine to analyze exhaled breath to learn about different illnesses in children and teens. It may help researchers find breathing “signals” that reflect conditions like breathing problems, nervous system issues, or new/worsening type 1 diabetes.
BaselAges Up to 22 years - NCT05265299RecruitingPhase 3
Testing the right aspirin dose for COPD symptoms
This Phase 3 trial studies which aspirin dose works best in people with COPD, with the goal of improving disease control. You may be asked to take aspirin and be monitored for safety, especially bleeding risk and heart/brain history.
Baltimore, MarylandAges 40–80 - NCT06038630RecruitingPhase 2
Xenon gas MRI study for lung and heart health
This study uses a special MRI scan (Xenon gas imaging) to look at how well your lungs and heart are working. It is for people with certain lung conditions, those getting blood transfusions or phlebotomy, or healthy volunteers.
Durham, North CarolinaAges 18 years+ - NCT06283004Recruiting
Walking training in COPD: comparing different slopes
This study tests whether walking on different types of slopes improves exercise ability in people with COPD. It aims to find the best slope training to help you breathe easier and walk farther.
Istanbul, Eyüp SultanAges 40 years+ - NCT06511284Recruiting
Nutrition therapy for swallowing problems after breathing tube removal
This study tests whether specialized nutrition therapy can help patients who have trouble swallowing after a breathing tube is removed. The goal is to improve recovery and quality of life for people who need a feeding tube after leaving the hospital.
Mexico CityAges 18 years+ - NCT06531460Recruiting
Omega-3 nutrition before lung cancer surgery
This study tests whether a special nutrition drink with omega-3 (a healthy fat found in fish) can help people recover better after lung cancer surgery. You may qualify if you are about to have lung removal surgery.
Mexico CityAges 18 years+ - NCT06644898Recruiting
Walking on slopes to improve balance in COPD
This study tests whether walking on different slopes (like hills) can help people with COPD improve their balance. It compares different types of incline walking to see which works best.
Istanbul, Eyüp SultanAges 40 years+ - NCT06810323Recruiting
Oxygen therapy study for COPD patients
This study tests a long-term oxygen therapy program for people with COPD who already use continuous oxygen at home. The goal is to see if regular at-home oxygen use improves breathing and quality of life over time.
Charlottesville, VirginiaAges Any age - NCT06844370Recruiting
Home vs hospital NIV care for MND
This study compares two ways of starting non-invasive ventilation (NIV) — a breathing machine — for people with motor neurone disease (MND). It aims to see if starting NIV at home is as safe and effective as starting it in the hospital.
CambridgeAges 18 years+ - NCT06918444Recruiting
Can a mobile app help you live healthier?
This trial tests a smartphone app called WARIFA that gives personalized advice to help prevent chronic diseases and manage diabetes. It is for healthy people or those with one chronic condition, and also for people with type 1 diabetes who use insulin and a continuous glucose monitor.
Las Palmas de Gran Canaria, Las PalmasAges 18 years+
Hear when a new Chronic Respiratory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for chronic respiratory disease?
- Yes. Clin2 currently lists 238 recruiting chronic respiratory disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a chronic respiratory disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a chronic respiratory disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.